Concepedia

Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease1

F. Smets, Dominique Latinne, Herv Bazin, Raymond Reding, Jean-Bernard Otté, Jean‐Paul Buts, Étienne Sokal

Transplantation · 2002 · 205 citations · 23 references

DOI

Abstract

We conclude that high viral load is systematic in patients who underwent primary EBV infection and is indicative of the PTLD risk only if there is low concomitant cellular immune response. Healing from PTLD requires modulation of immunosuppression, and appearance of EBV-TL.

References

23

REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY

Thomas E. Starzl, K. A. Porter, Shunzaburo Iwatsuki et al. · The Lancet · 1984 · 1.3K citations · Full text

, , +3

PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1

Sue V. McDiarmid, Stan Jordan, Geoffrey S. Lee et al. · Transplantation · 1998 · 343 citations

Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease

A Savoie, C Perpete, L. Carpentier et al. · Blood · 1994 · 274 citations · Full text

PATIENTS AT RISK FOR DEVELOPMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: PLASMA VERSUS PERIPHERAL BLOOD MONONUCLEAR CELLS AS MATERIAL FOR QUANTIFICATION OF EPSTEIN-BARR VIRAL LOAD BY USING REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION1,2

Hans-Joachim Wagner, Meike Wessel, Wolfram J. Jabs et al. · Transplantation · 2001 · 216 citations

Early Signs And Risk Factors For The Increased Incidence Of Epstein-Barr Virus-Related Posttransplant Lymphoproliferative Diseases In Pediatric Liver Transplant Recipients Treated With Tacrolimus

Étienne Sokal, Henedina Antunes, Claire Beguin et al. · Transplantation · 1997 · 185 citations